ArticleOncoimmunology2015

c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma.

Takumi Kumai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.